FSD Pharma (FSDDF) Short Interest Ratio & Short Volume

Short interest is the volume of FSD Pharma shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 900 shares of FSDDF short. Learn More on FSD Pharma's current short interest.

FSD Pharma saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 900 shares, an increase of 125.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to FSD Pharma: Repare Therapeutics Inc. (2.12%), Cardiff Oncology, Inc. (15.10%), Vaxart, Inc. (5.04%), Compugen Ltd. (1.48%), Cidara Therapeutics, Inc. (0.92%), Skye Bioscience, Inc. (11.33%), Cardiol Therapeutics Inc. (1.16%), Immunic, Inc. (4.22%), Telomir Pharmaceuticals, Inc. (3.85%), Zomedica Corp. (4.95%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($14.83 billion), Netflix, Inc. ($7.72 billion), Advanced Micro Devices, Inc. ($4.69 billion), Charter Communications, Inc. ($4.67 billion), Microchip Technology Incorporated ($3.40 billion), Centene Co. ($3.26 billion), Match Group, Inc. ($2.67 billion), Teladoc Health, Inc. ($2.31 billion), Snap Inc. ($2.24 billion), and Wayfair Inc. ($2.22 billion). View all of the most shorted stocks.

Short selling FSDDF is an investing strategy that aims to generate trading profit from FSD Pharma as its price is falling. FSDDF shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for FSD Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FSDDF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FSDDF, twice per month. The most recent reporting period available is December, 31 2019.